Natriuretic Peptide Receptor 2

Alternative Names

  • NPR2
  • Guanylate Cyclase B
  • GCB
  • GUC2B
  • GUCY2B
  • Atrial Natriuretic Peptide Receptor, Type B
  • ANPRB
  • Atrionatriuretic Peptide Receptor, Type B
  • NPRB
  • ANPB Receptor
Back to search Result
OMIM Number

108961

NCBI Gene ID

4882

Uniprot ID

P20594

Length

56,788

No. of Exons

24

No. of isoforms

2

Protein Name

Atrial natriuretic peptide receptor 2

Molecular Mass

117022

Amino Acid Count

1047

Genomic Location

9:35,752,945-35,809,732

Gene Map Locus
9p13.3

Description

The NPR2 gene encodes a homodimeric transmembrane receptor called natriuretic peptide receptor B. The latter binds to its extracellular ligand; C-type natriuretic peptide (CNP), which leads to the production of cGMP from GTP. 

NPR2 has 5 functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain.

The NPR2 gene is located on the short (p) arm of chromosome 9, and is 17.5 kb long with 22 exons. Mutations in NPR2 cause acromesomelic dysplasia Maroteaux type (AMDM), in which many types of mutations were identified (e.g. missense, frameshift, splice site and nonsense mutations). Moreover, obligate carriers of NPR2 mutations were shorter than average.

The mechanism by which missense mutations are thought to downregulate signaling through NPR2 involves arresting receptor trafficking at the endoplasmic reticulum due to a conformational change.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_003995.3:c.2304_2307delTTGGinsCTGATGGALebanon9:35806165:35806168Benign, Likely PathogenicAcromesomelic Dysplasia, Maroteaux TypeNG_009249.1:g.18757_18760delTTGGinsCTGATGGA; NM_003995.3:c.2304_2307delTTGGinsCTGATGGA; NP_003986.2:p.Trp769Ter
NM_003995.3:c.2869C>TOmanNC_000009.12:g.35808665C>TLikely PathogenicBenign, Likely PathogenicAcromesomelic Dysplasia, Maroteaux TypeNG_009249.1:g.21257C>T; NM_003995.3:c.2869C>T ; NP_003986.2:p.Arg957Cys1513451
NM_003995.3:c.3059delGLebanonchr9:35809228Benign, Likely PathogenicAcromesomelic Dysplasia, Maroteaux TypeNG_009249.1:g.21820delG ; NM_003995.3:c.3059delG; NP_003986.2:p.Arg1020fsTer1025
NM_003995.3:c.3079-49A>GUnited Arab EmiratesNC_000009.12:g.35809331A>GBenignAssociationType 2 Diabetes Mellitus; ObesityNG_009249.1:g.21923A>G; NM_003995.3:c.3079-49A>G; NP_003986.2:p.?22816451250991

Other Reports

Lebanon

Faivre et al. (2000) demonstrated linkage to 9p13-q12 in four Turkish consanguineous families with AMDM, but excluded this locus in a fifth Lebanese family, where two sibs, born to first cousin parents, had a mild form of AMDM with less marked shortening of the extremities and almost normal vertebra.

© CAGS 2024. All rights reserved.